Superdisintegrants

Superdisintegrants

Global Superdisintegrants Market to Reach US$567.2 Million by 2030

The global market for Superdisintegrants estimated at US$394.7 Million in the year 2023, is expected to reach US$567.2 Million by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Synthetic Superdisintegrants, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$262.2 Million by the end of the analysis period. Growth in the Natural Superdisintegrants segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$104.8 Million While China is Forecast to Grow at 9.3% CAGR

The Superdisintegrants market in the U.S. is estimated at US$104.8 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$134.5 Million by the year 2030 trailing a CAGR of 9.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Superdisintegrants Market - Key Trends and Drivers Summarized

Why Are Superdisintegrants Crucial for Modern Pharmaceuticals?

Superdisintegrants play a critical role in enhancing the performance of pharmaceutical dosage forms, particularly in the manufacturing of orally disintegrating tablets (ODTs) and fast-release formulations. These excipients accelerate the breakdown of tablets when they come into contact with water or bodily fluids, allowing for faster drug release and absorption. The growing preference for ODTs, especially among pediatric and geriatric patients who may have difficulty swallowing conventional tablets, has led to a surge in demand for superdisintegrants. Pharmaceutical manufacturers rely on superdisintegrants like crospovidone, sodium starch glycolate, and croscarmellose sodium to improve the efficiency and efficacy of their drug formulations, particularly for over-the-counter (OTC) and prescription medications.

What Are the Latest Innovations in Superdisintegrants?

Advancements in superdisintegrant technology are focused on improving the efficiency, compatibility, and safety of these excipients. Recent innovations include the development of natural and biodegradable superdisintegrants, which are gaining popularity due to their eco-friendly nature. Additionally, pharmaceutical companies are experimenting with multifunctional superdisintegrants that offer not only rapid disintegration but also improved drug stability and bioavailability. The rise of novel drug delivery systems, such as sublingual and buccal tablets, has further expanded the scope of superdisintegrants in modern formulations. Continuous R&D efforts are aimed at reducing disintegration times and optimizing the functionality of these excipients in different drug matrices.

Which Market Segments Are Leading in Superdisintegrants?

Key product types include synthetic superdisintegrants such as crospovidone and sodium starch glycolate, which dominate the market due to their high efficiency. Natural superdisintegrants like modified starches and cellulose are gaining traction as clean-label options for pharmaceutical companies. In terms of formulation, orally disintegrating tablets (ODTs) and fast-release capsules account for the largest share of the market. The pharmaceutical sector is the primary end-user of superdisintegrants, with applications in both prescription and OTC drugs. North America and Europe hold the largest market shares due to the advanced pharmaceutical infrastructure, while Asia-Pacific is expected to witness rapid growth due to increasing drug production.

What Drives Growth in the Superdisintegrants Market?

The growth in the Superdisintegrants market is driven by several factors, including the increasing demand for fast-acting and patient-friendly drug formulations, advancements in drug delivery systems, and the rising prevalence of chronic diseases that require ongoing medication. The growing pediatric and geriatric populations, who benefit the most from orally disintegrating tablets, are also fueling demand. Additionally, regulatory support for improving patient compliance and the increasing popularity of nutraceuticals and dietary supplements are expanding the application of superdisintegrants. The focus on innovation, particularly in natural and multifunctional superdisintegrants, is contributing to sustained market growth.

Select Competitors (Total 46 Featured) -

• Asahi Kasei Corporation
• Ashland Global Holdings, Inc.
• Avantor Performance Materials LLC
• BASF SE
• Corel Pharma Chem
• DFE Pharma GmbH & Co. KG
• Dow, Inc.
• DuPont de Nemours, Inc.
• Jrs Pharma GmbH Co. KG
• Merck KgaA
• Roquette Freres S.A.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.